EFFICACY AND SAFETY OF WEIGHT-BASED VERSUS FIXED-DOSE 4F-PCC FOR DIRECT ORAL ANTICOAGULANT REVERSAL

被引：0
作者：
Woodfield, Emily [1 ]
Thomas, Miranda [1 ]
Milkovits, Ashley [1 ]
Barnes, Chase [1 ]
McAllister, Kelly [2 ]
Hornsby, Matthew [1 ]
机构：
[1] Carilion Roanoke Mem Hosp, Roanoke, VA USA
[2] Carilion Clin, Roanoke, VA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
819
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis
    Keyhan Mohammadi
    Shakila Yaribash
    Mahmood Alizadeh Sani
    Azita Hajhossein Talasaz
    Cardiovascular Drugs and Therapy, 2022, 36 : 533 - 546
  • [22] Efficacy and Safety of Prothrombin Complex Concentrate (PCC) for Direct Oral Anticoagulant Reversal: A Single Institutional Experience
    Sridharan, Meera
    Ou, Narith N.
    Oyen, Lance J.
    Ashrani, Aneel A.
    McBane, Robert D.
    Pruthi, Rajiv K.
    BLOOD, 2018, 132
  • [23] EFFICACY AND SAFETY OF 4F-PCC VS. FFP FOR WARFARIN REVERSAL IN EMERGENT SURGERY/INVASIVE PROCEDURE
    Mazur, Hannah
    Young, Sarah
    McGraw, Molly
    Montepara, Courtney
    CRITICAL CARE MEDICINE, 2019, 47
  • [24] COMPARISON OF WEIGHT-BASED VERSUS FIXED-DOSE INHALED EPOPROSTENOL IN CRITICALLY ILL ARDS PATIENTS
    Buckley, Mitchell
    Mendez, Angel
    Radosevich, John
    Agarwal, Sumit
    MacLaren, Robert
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 433 - 433
  • [25] Efficacy and safety of fixed-dose oral sildenafil - Reply by the author
    Montague, DK
    UROLOGY, 1999, 54 (02) : 384 - 384
  • [26] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Pansy Elsamadisi
    Mark A. G. Cepeda
    Tuyen Yankama
    Adrian Wong
    Qua Tran
    Ifeoma Mary Eche
    American Journal of Cardiovascular Drugs, 2021, 21 : 355 - 361
  • [27] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Elsamadisi, Pansy
    Cepeda, Mark A. G.
    Yankama, Tuyen
    Wong, Adrian
    Tran, Qua
    Eche, Ifeoma Mary
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) : 355 - 361
  • [28] COMPARISON OF 4F-PCC FOR REVERSAL OF DOAC VERSUS WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Pasciolla, Stacy
    Wojcik, Kevin
    Evans, Danielle
    Shaikh, Hamza
    Jankowitz, Brian
    Igneri, Lauren
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 352 - 352
  • [29] Comparison of 4F-PCC and aPCC time to administration and outcomes for oral anticoagulant-related ICH
    Lin, Stacy
    Cunningham, Brittany
    Mullen, Chanda
    Simon, Erin
    Bice, Deanna
    Garlock, Jenna
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 56 : 183 - 187
  • [30] SAFETY OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES (4F-PCC) FOR THE REVERSAL OF FACTOR XA INHIBITORS
    Tao, Jing
    Bukanova, Elena
    Akhtar, Shamsuddin
    ANESTHESIA AND ANALGESIA, 2018, 126 (04) : 98 - 100
12345